Human papillomavirus (HPV) vaccination reduced the risk of cancer for men as well as women, according to study findings presented at the American Society of Clinical Oncology Annual Meeting (ASCO 2024) in Chicago. Another recent study offers further real-world evidence that the vaccine has dramatically lowered cervical cancer incidence in the United Kingdom. But only a minority of adolescents and young adults in the United States have received the vaccine.
“This study adds to a growing body of evidence demonstrating decreased rates of HPV-related cancer among people who received the HPV vaccination,” Jefferson DeKloe, a research fellow at Thomas Jefferson University, said in an ASCO news release.
Read the full story at POZ.
Source : POZ
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.